|
MCID: SPN136
|
Spondyloepimetaphyseal Dysplasia, Aggrecan Type malady |
|
Sources: 33OMIM, 22MalaCards See all sources Export this MalaCard |
|
Sources: 30NIH Rare Diseases, 33OMIM, 43UMLS See all sources |
|
|
|
Sources: 33OMIM See all sources |
Clinical features from OMIM: 612813
|
|
Sources: 4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials See all sources |
Approved drugs:Search CenterWatch for spondyloepimetaphyseal dysplasia, aggrecan type Drug clinical trials:Search ClinicalTrials for spondyloepimetaphyseal dysplasia, aggrecan type Search NIH Clinical Center for spondyloepimetaphyseal dysplasia, aggrecan type Search CenterWatch for spondyloepimetaphyseal dysplasia, aggrecan type |
|
|
|
|
Phenotypes for genes affiliated with Spondyloepimetaphyseal Dysplasia, Aggrecan Type
|
|
Publications for genes affiliated with Spondyloepimetaphyseal Dysplasia, Aggrecan Type
|
|
Expression for genes affiliated with Spondyloepimetaphyseal Dysplasia, Aggrecan Type
|
Sources: 1BioGPS See all sources |
![]() |
Pathways for genes affiliated with Spondyloepimetaphyseal Dysplasia, Aggrecan Type
|
|
Compounds for genes affiliated with Spondyloepimetaphyseal Dysplasia, Aggrecan Type
|
|
GO Terms for genes affiliated with Spondyloepimetaphyseal Dysplasia, Aggrecan Type
|
|
